A study in healthy subjects designed to evaluate the pharmacokinetic profile of firibastat (QGC001) and metabolites EC33 and QGC515 following multiple dose administration of QGC001 immediate release and modified release formulations
Latest Information Update: 02 Mar 2022
At a glance
- Drugs Firibastat (Primary)
- Indications Heart failure; Hypertension; Left ventricular dysfunction
- Focus Pharmacokinetics
- Sponsors Quantum Genomics
Most Recent Events
- 02 Mar 2022 New trial record